🕒 Monday 16 March 2026 Mon, 16 Mar 2026

Barton Gold Holdings has launched Phase 2 drilling at its Tunkillia Gold Project, aiming to upgrade resources and fast-track a mining lease application by year-end. The project’s strong economics and rising gold and silver prices underpin an optimistic development outlook.

Southern Cross Gold Consolidated Ltd has reported record-breaking high-grade gold and antimony intersections from its Sunday Creek project in Victoria, revealing a consistent and expanding mineral system at shallow depths.

ABx Group has announced a breakthrough with its second mixed rare earth carbonate sample from Tasmania’s Deep Leads deposit, boasting higher heavy rare earth content and fewer impurities. This advancement enhances project flexibility and strengthens ABx’s position in the competitive rare earths market.

OD6 Metals has significantly expanded its claim holdings around the Quinn Fluorspar Project in Nevada, securing promising new exploration targets including the large Dresser epithermal alteration zone. This move strengthens its position in a critical mineral district vital to US supply chains.

Jupiter Mines has announced a modest interim dividend of 0.55 cents per share for H1 FY2026, reflecting ongoing shareholder returns despite a lower payout ratio compared to previous years.

NH3 Clean Energy has locked in a crucial 15-year water supply agreement with the Water Corporation of WA for its flagship WAH2 clean ammonia project, marking a key step towards its final investment decision.

Perpetual Limited has agreed to sell its Wealth Management business to Bain Capital for an upfront $500 million, marking a strategic shift towards asset management and corporate trustee services.

Calix Limited has successfully completed the first milestone of its ARENA grant for the Zesty Green Iron Demonstration Project, unlocking a $2 million payment and marking a key step forward in its industrial decarbonisation efforts.

Strike Energy reports a significant 35% increase in the Benchmark Reserve Capacity Price for 2028/29, alongside strong construction progress at its South Erregulla Power Project, signalling robust prospects for WA’s energy transition.

Dataworks Group Limited reveals ongoing strategic review with several parties engaged, highlighting the value of its self-exclusion technology and regulatory ties. While discussions remain preliminary, the company signals potential for significant strategic moves ahead.

PTR Minerals reports promising initial metallurgical test outcomes and consistent high-grade drilling at its Rosewood Titanium Project, setting the stage for a maiden resource estimate in Q2 2026.

Dimerix Limited is set to conduct a blinded statistical review of its pivotal Phase 3 ACTION3 study in March 2026, aiming to confirm the trial remains powered to demonstrate the primary endpoint of proteinuria reduction in FSGS patients.

Syrah Resources has secured an extension to the cure date for an alleged default under its Tesla offtake agreement, pushing the deadline from March to June 2026 as both parties work to resolve outstanding issues.

Neurizon Therapeutics announces the resignation of CEO Dr Michael Thurn, with Executive Chair Sergio Duchini stepping in temporarily as the company embarks on a global hunt for new leadership.

Telix Pharmaceuticals has resubmitted its New Drug Application to the FDA for TLX101-Px (Pixclara®), aiming to advance a novel PET imaging agent for glioma diagnosis. The resubmission addresses prior regulatory concerns with additional data, reinforcing hopes for expedited approval.

Bio-Gene has signed a term sheet with Sumitomo Corporation and Nakashima Trading to introduce its 100% natural insecticide Qcide® to Japan’s $1 billion household pest market, aiming for a late 2026 launch.

Ore Resources Ltd has acquired four new prospecting licenses adjacent to its Coolgardie Gold and Lithium Project, expanding its landholding to over 80 square kilometres. The company plans systematic exploration targeting promising historical gold intercepts, with drilling set for early Q3 2026.

FAR Limited has agreed on a provisional US$23.7 million contingent payment from Woodside Energy tied to the Sangomar Project, prompting a proposed capital return of A$32.3 million to shareholders.

Tetratherix Limited launches a new precision medicine franchise leveraging its Tetramatrix™ platform, securing a decade-long exclusive partnership with US health group Superpower Health Inc. This deal promises immediate revenue and complements ongoing FDA milestones.

Reliance Worldwide Corporation has announced an additional A$120 million on-market share buy-back, reinforcing its confidence in the company’s strategy and financial health.

EMVision Medical Devices has secured a $3.8 million R&D tax rebate and gained approval to claim rebates on overseas expenditures, strengthening its financial footing as it advances clinical trials for its neurodiagnostic device.

Tali Resources is ramping up exploration at its West Arunta Project with a 10,000m drilling campaign and extensive geophysical surveys targeting copper, gold, and critical minerals.

Estrella Resources has completed its 2025 drilling program at the Werumata Limestone Project in Timor-Leste, reporting broad, high-grade limestone and chalk intersections that pave the way for a maiden JORC resource estimate.

West Cobar Metals has significantly expanded its exploration tenure in NSW’s Cobar district by applying for two new licences, increasing its coverage to around 1,090 km² and unlocking fresh potential for copper, gold, antimony, and silver discoveries.